Institutional Ownership
West Pharmaceutical Svsc Inc
CUSIP 955306105COMWSTQ1 2026
Latest EPS (Diluted)
$2.15
Q2 2026 · Jun 30, 2026
Latest Revenue
$872.30M
Reported quarter
Latest Net Income
$154.00M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $2.17 | $2.15 | $872.30M | $154.00M | 10-Q |
| Mar 31, 2026 | Q1 2026 | $1.93 | $1.92 | $844.90M | $138.80M | 10-Q |
| Sep 30, 2025 | Q3 2025 | $1.94 | $1.92 | $804.60M | $140.00M | 10-Q |
| Jun 30, 2025 | Q2 2025 | $1.82 | $1.82 | $766.50M | $131.80M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $1.24 | $1.23 | $698.00M | $89.80M | 10-Q |
| Sep 30, 2024 | Q3 2024 | $1.87 | $1.85 | $746.90M | $136.00M | 10-Q |
| Jun 30, 2024 | Q2 2024 | $1.52 | $1.51 | $702.10M | $111.30M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $1.57 | $1.55 | $695.40M | $115.30M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $2.17 | $2.14 | $747.40M | $161.30M | 10-Q |
| Jun 30, 2023 | Q2 2023 | $2.08 | $2.06 | $753.80M | $155.10M | 10-Q |
| Mar 31, 2023 | Q1 2023 | $1.88 | $1.85 | $716.60M | $140.00M | 10-Q |
| Sep 30, 2022 | Q3 2022 | $1.62 | $1.59 | $686.90M | $120.60M | 10-Q |